[{"name":"Novel Anti-HER2-Directed ADCs (ID 835)","mode":"","is_cme":false,"info":{"presentation":"Novel Anti-HER2-Directed ADCs <small>(ID 835)<\/small>","session":"CME Webinar Supported by Daiichi Sankyo - Industry Satellite Symposium: Novel Therapies for Relapsed or Refractory HER2- Positive Metastatic Breast Cancer <small>(ID 83)<\/small>","presenter":"Adam M. Brufsky<small> (Pittsburgh, PA, United States of America)<\/small>","photo":null},"playlist":[{"name":"Novel Anti-HER2-Directed ADCs","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/breast2020\/83\/v\/835_1c.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/breast2020\/83\/v\/835_1c.mp4","cover":"","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/breast2020\/83\/v\/835_1c.vtt","thumbnails":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/breast2020\/83\/v\/835_1c-thumbnails.vtt"}]}]{"provider":"CTI","provider_live":0,"type":1,"code":"6L240fp02Vk"}